Preliminary Scientific Program

Diagnostics and staging

  • Rational use of imaging methods in gynecological oncology
  • Preoperative staging of pelvic masses
  • Assessment of lymph nodes by US, PET and MRI
  • Pelvic side wall anatomy and assessment
  • Imaging guided procedures

Live ultrasound scanning

LIVE demonstration of ultrasound examination of patients with gynecological tumors.

Systemic treatment

• Systemic treatment of ovarian cancer

  • What is BRCA, HRD, HRR, and how they are tested
  • Biomarkers in ovarian cancer – which and when
  • Current SoA chemotherapy
  • Maintenance treatment in 1L and beyond

• Platinum resistant recurrent ovarian cancer (PROC)

  • Current SoA treatment of PROC
  • What is ADC and how it works
  • Predictive biomarkers and their testing
  • First ADC approved in ovarian cancer in Europe
  • Challenging management of new types of toxicity

• Management of locally advanced and metastatic cervical cancer

  • Chaos in classification (intermediate/ high risk, IB3, locally advanced disease)
  • What is the current standard treatment in locally advanced cervical cancer (chemoradiotherapy vs induction chemotherapy vs immunotherapy)
  • First line treatment of metastatic disease
  • Tips how to manage toxicity and enhance treatment compliance

• Endometrial cancer

  • Molecular classification in endometrial cancer for beginners
  • Indications of adjuvant treatment in the molecular era
  • Systemic treatment of metastatic and recurrent endometrial cancer

• Immunotherapy and endocrine treatment

  • A guide to cancer immunotherapy
  • Principles of cancer immunotherapy strategies
  • Endocrine treatment in gynecological tumors
  • The role of NGS and molecular tumor boards in current management

Surgical treatment

• Early stages

  • Surgical treatment of non-epithelial and other rare ovarian tumors
  • Surgical treatment of early-stage cervical cancer in the “after SHAPE” era
  • Sentinel lymph nodes in gynecological cancers
  • Management of patients with micrometastases and isolated tumor cells in SLN

• Fertility sparing treatment

  • Fertility preservation in cervical cancer
  • Fertility preservation in endometrial cancer
  • Management of gynecological tumors in pregnancy

• Advanced stages

  • Secondary cytoreduction in ovarian and endometrial cancer
  • Pelvic exenterations, LEER and out-of-box procedures

Videosession

Demonstration of main radical surgical procedures step by step.

Perioperative and palliative care

  • Implementation of ERAS and prehabilitation into the routine practice
  • Early palliative care and best supportive care in gynecological oncology
  • Communicating serious news effectively: Tips and tricks for a person-centered approach
SAGO 2025 SECRETARIAT
GUARANT International spol. s r.o.
Českomoravská 19, 190 00  Prague 9, Czech Republic
Phone: +420 284 001 444
E-mail: sago-secretariat@guarant.cz | Website: www.guarant.cz